The German telecommunications group said Thursday that expectations of faster growth mean it aims to have 15 billion euros ($16.41 billion) in available cash by 2027 to either increase its stake in ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The concerns surrounding Zantac also prompted UK health authorities to advise doctors in 2019 to cease prescribing specific formulations of the drug as a precautionary measure. Reports indicated that ...

Bar Rua on the corner of Clarendon Street and Chatham Row/Chatham Street has been put on the market as Galway Bay Brewery ...

(Rodriguez, 9/19) Reuters: GSK Settles Two California Lawsuits Related To Heartburn Drug Zantac British drugmaker GSK said ... The company said the pricing would be available to eligible U.S. military ...

The company also said on Wednesday that it had reached another agreement in principle to pay $70 million to settle a separate Zantac case with US laboratory Valisure—which is still subject to ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...

GSK’s move doesn’t end litigation around Zantac as other drugmakers are still facing trials, including Boehringer Ingelheim GmbH, which is facing a jury trial in Oakland.

GSK has agreed to pay up to $2.2 billion to resolve approximately 80,000 lawsuits brought by users of Zantac who claimed the heartburn drug caused their cancer. The agreement frees the British ...

GSK’s move doesn’t end litigation around Zantac as other drugmakers are still facing trials, including Boehringer Ingelheim GmbH, which is facing a jury trial in Oakland. Click to share on ...

GSK has agreed in principle to pay $70 million to resolve a separate qui tam complaint related to Zantac, initially filed by Valisure. This settlement is still subject to final approval from the ...